Omniome

About:

Omniome engages in developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.

Website: http://www.omniome.com/

Twitter/X: omniome

Top Investors: ARCH Venture Partners, Hillhouse Investment, Decheng Capital, EvoNexus, Domain Associates

Description:

Omniome engages in developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy. Backed by leading life sciences venture investors and a proven management team, Omniome’s vision is to be the most trusted DNA sequencing platform and leader in clinical sequencing. Founded in 2013, the company is headquartered in San Diego, California, United States.

Total Funding Amount:

$127M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2013-01-01

Contact Email:

hello(AT)omniome.com

Founders:

Eugene Tu, Kandaswamy Vijayan, Millard Chan

Number of Employees:

101-250

Last Funding Date:

2020-01-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai